Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

NCT05175404 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05175404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
January 24, 2022
Completion date
July 18, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer